Cofoe Medical Technology Co., Ltd. (301087.SZ) has submitted a listing application to the main board of the Hong Kong Stock Exchange, with Huatai International and BNP Paribas serving as joint sponsors. This marks the company's second attempt to list in Hong Kong, following a previous application submitted on August 29, 2025. According to its prospectus, Cofoe Medical is one of China's largest home medical device companies. Data from Frost & Sullivan shows that based on domestic revenue in 2024, the company ranked second among all home medical device enterprises in China, capturing a market share of 2.1%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments